-
1
-
-
17544404426
-
-
Raloxifen displays estrogen agonist-like actions on bone tissues and serum lipids while displaying potent estrogen antagonist properties in the breast and uterus. See for example: J.A. Dodge, C.W. Lugar, S. Cho, L.L. Short, M. Sato, N.N. Yang, L.A. Spangle, M.J. Martin, D.L. Phillips, A.L. Glasebrook, J.J. Osborne, C.A. Frolik, and H.U. Bryant J. Steroid Biochem. Mol. Biol. 61 1997 97 106
-
(1997)
J. Steroid Biochem. Mol. Biol.
, vol.61
, pp. 97-106
-
-
Dodge, J.A.1
Lugar, C.W.2
Cho, S.3
Short, L.L.4
Sato, M.5
Yang, N.N.6
Spangle, L.A.7
Martin, M.J.8
Phillips, D.L.9
Glasebrook, A.L.10
Osborne, J.J.11
Frolik, C.A.12
Bryant, H.U.13
-
3
-
-
0035833063
-
-
D. Lesuisse, E. Albert, F. Bouchoux, E. Cerede, J.-M. Lefrancois, M.-O. Levif, S. Tessier, B. Tric, and G. Teutsch Bioorg. Med. Chem. Lett. 11 2001 1709 1712
-
(2001)
Bioorg. Med. Chem. Lett.
, vol.11
, pp. 1709-1712
-
-
Lesuisse, D.1
Albert, E.2
Bouchoux, F.3
Cerede, E.4
Lefrancois, J.-M.5
Levif, M.-O.6
Tessier, S.7
Tric, B.8
Teutsch, G.9
-
10
-
-
0001086486
-
-
C.-M. Liu, B.-H. Chen, W.-Y. Liu, X.-L. Wu, and Y.-X. Ma J. Organomet. Chem. 598 2000 348 352
-
(2000)
J. Organomet. Chem.
, vol.598
, pp. 348-352
-
-
Liu, C.-M.1
Chen, B.-H.2
Liu, W.-Y.3
Wu, X.-L.4
Ma, Y.-X.5
-
13
-
-
0001377704
-
-
M. Larhed, M. Hoshino, S. Hadida, D.P. Curran, and A. Hallberg J. Org. Chem. 62 1997 5583 5587
-
(1997)
J. Org. Chem.
, vol.62
, pp. 5583-5587
-
-
Larhed, M.1
Hoshino, M.2
Hadida, S.3
Curran, D.P.4
Hallberg, A.5
-
17
-
-
0035840344
-
-
C. Dupuis, K. Adiey, L. Charruault, V. Michelet, M. Savignac, and J.-P. Genet Tetrahedron Lett. 42 2001 6523 6526
-
(2001)
Tetrahedron Lett.
, vol.42
, pp. 6523-6526
-
-
Dupuis, C.1
Adiey, K.2
Charruault, L.3
Michelet, V.4
Savignac, M.5
Genet, J.-P.6
-
19
-
-
78650012736
-
-
note
-
2O in methanol, B: 25% isopropanol in methanol). The response areas in the HPLC analysis (UV 260 nm) of the desired biaryl peak in the crude product and in the crude product spiked with a known amount of isolated biaryl compound were determined and the amount of biaryl compound in the crude product was determined from the difference between the spiked and non-spiked samples.
-
-
-
-
22
-
-
78650026981
-
-
note
-
Method B: A stirred mixture of bromo component (2.0 mmol), tris(dibenzylidene-acetone)dipalladium (0.1 mmol) and trifurylphosphine (0.4 mmol, 5 mol %) in DMF (8 mL) was purged with argon for 10 min. 4-trimethyl-stannylbenzaldehyde (0.67 g, 2.5 mmol) was added to the reaction mixture and heating was set to 65 °C. When no further development could be observed (TLC), ethyl acetate and activated carbon were added and the mixture was set to reflux for 15 min, after which it was filtered through a short pad of Celite (1 cm) on silica (1 cm) in a glass filter funnel. The filtrate was evaporated and the residue was further purified on HPLC. Yields were determined using HPLC as described above under Method A.
-
-
-
|